Exact Sciences Corp (EXAS)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$51.50
Buy
$53.65
$-1.43 (-2.70%)
Prices updated at 10 May 2025, 00:55 EDT
| Prices minimum 15 mins delay
Prices in USD
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Kevin T. Conroy
CEO
Mr. Kevin T. Conroy
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,000
Head office
5505 Endeavor Lane
Madison
United States
53719
Key personnel
Owner name | Salary |
---|---|
Ms. Leslie L. Trigg Director | - |
Ms. Kimberly J. Popovits Director | - |
Ms. Katherine S. Zanotti Independent Director | 0.09m |
Mr. Kevin T. Conroy Chairman of the Board, President and Chief Executive Officer | 1.08m |
Mr. Paul J. Clancy, M.B.A. Independent Director | 0.10m |
Mr. Daniel Joseph Levangie Independent Director | 0.09m |
Mr. Jacob Orville Executive Vice President and General Manager, Screening | 0.62m |
Mr. James E. Doyle Lead Independent Director | 0.13m |
Mr. D. Scott Coward Director | 0.08m |
Ms. Shacey Petrovic Independent Director | 0.09m |
Ms. Sarah Condella Executive Vice President, Human Resources | 0.51m |
Mr. Michael J. Barber Independent Director | 0.10m |
Mr. Brian Baranick Executive Vice President and General Manager, Precision Oncology | 0.60m |
Mr. James Herriott Senior Vice President, General Counsel and Secretary | - |
Mr. Aaron Bloomer Executive Vice President, Chief Financial Officer and Principal Accounting Officer | 0.43m |
Top 5 shareholders
Owner name | No. of shares |
---|---|
FMR LLC | 22,042,464 |
FMR Inc | 20,753,505 |
Fidelity Management and Research Company | 20,753,505 |
Capital Research and Management Company | 17,833,040 |
Capital World Investors | 17,537,617 |
Director dealings
Date | Action |
---|---|
14 May 2024 | - |
13 Nov 2024 | - |
08 Oct 2024 | - |
18 Sep 2024 | - |
05 Aug 2024 | - |
05 Aug 2024 | - |
05 Aug 2024 | - |
05 Aug 2024 | - |
05 Aug 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
13 Jun 2024 | - |
30 Apr 2024 | - |
01 May 2024 | - |
01 May 2024 | - |
Please note that past performance is not a reliable indicator of future returns.